Uncategorized
Beyond The Numbers: 11 Analysts Discuss IAC Stock
Latest Ratings for IAC Date Firm Action From To Feb 2022 BMO Capital Maintains Outperform Feb 2022 Credit Suisse Maintains Outperform Feb 2022 Piper Sandler Maintains Overweight View More Analyst Ratings for IAC View the Latest Analyst Ratings read more
Expert Outlook: Dow Through The Eyes Of 15 Analysts
Latest Ratings for DOW Date Firm Action From To Jan 2022 Goldman Sachs Maintains Neutral Jan 2022 Goldman Sachs Maintains Neutral Jan 2022 Mizuho Maintains Neutral View More Analyst Ratings for DOW View the Latest Analyst Ratings read more
Assessing Confluent: Insights From 11 Financial Analysts
Latest Ratings for CFLT Date Firm Action From To Feb 2022 Deutsche Bank Maintains Hold Feb 2022 Credit Suisse Maintains Outperform Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for CFLT View the Latest Analyst Ratings read more
5 Analysts Assess Cullen/Frost Bankers: What You Need To Know
Latest Ratings for CFR Date Firm Action From To Jan 2022 Raymond James Upgrades Underperform Market Perform Dec 2021 Morgan Stanley Maintains Underweight Nov 2021 Morgan Stanley Maintains Underweight View More Analyst Ratings for CFR View the Latest Analyst Ratings read more
FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief
FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options. read more
Bitcoin, XRP, Dogecoin Pull Back On Trump Tariff Announcement, Ethereum Hanging On
Cryptocurrency markets are under pressure on Friday after President Trump’s tariff announcement. read more
